Search results for "Receiver"

showing 10 items of 308 documents

Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning

2021

Recent evidence suggests that, in some foci, elimination of onchocerciasis from Africa may be feasible with mass drug administration (MDA) of ivermectin. To achieve continental elimination of transmission, mapping surveys will need to be conducted across all implementation units (IUs) for which endemicity status is currently unknown. Using boosted regression tree models with optimised hyperparameter selection, we estimated environmental suitability for onchocerciasis at the 5 × 5-km resolution across Africa. In order to classify IUs that include locations that are environmentally suitable, we used receiver operating characteristic (ROC) analysis to identify an optimal threshold for suitabil…

OncocercosisDecision AnalysisRC955-962Onchocerciasislaw.inventionGeographical LocationsMedical Conditions0302 clinical medicinelawArctic medicine. Tropical medicineMedicine and Health Sciences030212 general & internal medicineOnchocerca11 Medical and Health SciencesData ManagementbiologyPharmaceuticswc_695Enfermedades ParasitariasOnchocerciasi3. Good healthInfectious DiseasesGeographyTransmission (mechanics)Helminth InfectionsEngineering and TechnologyMass Drug AdministrationOnchocercaPublic aspects of medicineRA1-1270Management EngineeringCartographyHumanResearch ArticleNeglected Tropical DiseasesComputer and Information SciencesDrug Administration030231 tropical medicineDecision treewa_395Dermatologywc_765Environmentwc_885Research and Analysis MethodsSkin Diseases03 medical and health sciencesDrug TherapySDG 3 - Good Health and Well-beingDiagnostic MedicineTropical MedicineParasitic DiseasesmedicineHumansDisease EradicationSpatial analysisIvermectinData collectionReceiver operating characteristicData VisualizationDecision TreesPublic Health Environmental and Occupational Health06 Biological SciencesOnchocerciasis ; Elimination planning ; Africa ; Implementation units ; Public healthTropical Diseasesmedicine.diseasebiology.organism_classificationHealth CareROC CurvePeople and PlacesAfricaHealth StatisticsMorbidityOnchocerciasisScale (map)ForecastingPLOS Neglected Tropical Diseases
researchProduct

Prognostic impact of phosphorylated HER-2 in HER-2+ primary breast cancer.

2011

Abstract Purpose. Tyrosine 1248 is one of the autophosphorylation sites of human epidermal growth factor receptor (HER)-2. We determined the prognostic value of the expression level of tyrosine 1248–phosphorylated HER-2 (pHER-2) in patients with HER-2+ primary breast cancer using a reverse-phase protein array. Patients and Methods. The optimal cutoff value of pHER-2 for segregating disease-free survival (DFS) was determined by receiver operating characteristic (ROC) curve analysis. Five-year DFS for pHER-2 expression level was estimated with the Kaplan-Meier method using both derivation (n = 162) and validation (n = 227) cohorts. Results. Of the 162 patients in the derivation cohort, 26 had…

OncologyAdultCancer Researchmedicine.medical_specialtyPathologyReceptor ErbB-2Breast NeoplasmsMetastasesDisease-Free SurvivalBreast cancerBreast cancerReverse-phase protein arrayInternal medicineBreast CancermedicineHumansTyrosinePhosphorylationIn Situ Hybridization FluorescenceAgedAged 80 and overReceiver operating characteristicintegumentary systembusiness.industryAutophosphorylationReverse phase protein lysate microarrayMiddle Agedmedicine.diseasePrognosisImmunohistochemistryOncologyHER-2PhosphorylationImmunohistochemistryFemalePrimary breast cancerbusinessThe oncologist
researchProduct

Circulating miR-30b-5p levels in plasma as a novel potential biomarker for early detection of breast cancer

2021

Background Recently, microRNAs have been demonstrated to be potential non-invasive biomarkers for diagnosis, prognosis assessment or prediction of response to treatment in cancer. In this study, we evaluate the potential of miR-30b-5p as a biomarker for early diagnosis of breast cancer (BC) in tissue and plasma. Methods Expression of miR-30b-5p was determined in a series of 112 BC and 40 normal breast tissues. Circulating miR-30b-5p levels in plasma samples were determined in a discovery cohort of 38 BC patients and 40 healthy donors and in a validation cohort of 83 BC patients and 83 healthy volunteers. miR-30b-5p expression was measured by quantitative real-time PCR and receiver operating…

OncologyCancer Researchmedicine.medical_specialtydiagnosisBreast NeoplasmsBreast cancerbreast cancerPositive axillary lymph nodeInternal medicinemicroRNAmedicineBiomarkers TumorHumansStage (cooking)plasmaEarly Detection of CancerOriginal ResearchReceiver operating characteristicmicroRNAbusiness.industryCancermedicine.diseasePrognosisMicroRNAsOncologyCohortBiomarker (medicine)FemalebusinessESMO Open
researchProduct

Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer.

2017

The purpose of this study was to investigate the role of features derived from breast dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and to incorporated clinical information to predict the molecular subtypes of breast cancer. In particular, 60 breast cancers with the following four molecular subtypes were analyzed: luminal A, luminal B, human epidermal growth factor receptor-2 (HER2)-over-expressing and basal-like. The breast region was segmented and the suspicious tumor was depicted on sequentially scanned MR images from each case. In total, 90 features were obtained, including 88 imaging features related to morphology and texture as well as dynamic features from tumor and …

OncologyCancer Treatmentlcsh:MedicineInvasive Ductal CarcinomaLogistic regression030218 nuclear medicine & medical imagingDiagnostic Radiology0302 clinical medicineMathematical and Statistical TechniquesBreast TumorsImage Processing Computer-AssistedMedicine and Health Scienceslcsh:ScienceMultidisciplinarymedicine.diagnostic_testHuman epidermal growth factorRadiology and ImagingMiddle AgedMagnetic Resonance ImagingOncology030220 oncology & carcinogenesisArea Under CurvePhysical SciencesFemaleAlgorithmsStatistics (Mathematics)Research ArticleAdultmedicine.medical_specialtyImaging TechniquesImage processingBreast NeoplasmsResearch and Analysis MethodsCarcinomasSkewness03 medical and health sciencesBreast cancerText miningDiagnostic MedicineInternal medicineImage Interpretation Computer-AssistedBreast CancermedicineBiomarkers TumorHumansStatistical MethodsDifferentiated TumorsAgedNeoplasm StagingReceiver operating characteristicbusiness.industrylcsh:RCancers and NeoplasmsMagnetic resonance imagingLuminal amedicine.diseaseImage EnhancementProbability TheoryProbability Distributionlcsh:QNeoplasm GradingbusinessMathematicsForecastingPloS one
researchProduct

A Tetra-Panel of Serum Circulating miRNAs for the Diagnosis of the Four Most Prevalent Tumor Types

2020

The purpose of this study is to clinically validate a series of circulating miRNAs that distinguish between the 4 most prevalent tumor types (lung cancer (LC)

OncologyMaleLung NeoplasmsColorectal cancerlcsh:ChemistryProstate cancer0302 clinical medicinelcsh:QH301-705.5SpectroscopyEarly Detection of CancerAged 80 and over0303 health sciencesArea under the curveGeneral MedicineMiddle AgedEarly diagnosisprostate cancer3. Good healthComputer Science Applications030220 oncology & carcinogenesisArea Under CurveFemaleColorectal NeoplasmsAdultmedicine.medical_specialtyBreast Neoplasmscolorectal cancerCatalysisArticleInorganic Chemistry03 medical and health sciencesBreast cancerbreast cancerInternal medicinemedicineHumansCirculating MicroRNAPhysical and Theoretical ChemistryLung cancerMolecular Biology030304 developmental biologyAgedNeoplasm StagingReceiver operating characteristicbusiness.industryOrganic ChemistryCancerProstatic Neoplasmsmedicine.diseaseCirculating MicroRNAlung cancerlcsh:Biology (General)lcsh:QD1-999ROC CurveCase-Control StudiesMultivariate Analysiscirculating microRNAsbusinessInternational Journal of Molecular Sciences
researchProduct

Prediction of Non-sentinel Node Status in Patients with Melanoma and Positive Sentinel Node Biopsy: An Italian Melanoma Intergroup (IMI) Study

2018

Background and Purpose: Approximately 20% of melanoma patients harbor metastases in non-sentinel nodes (NSNs) after a positive sentinel node biopsy (SNB), and recent evidence questions the therapeutic benefit of completion lymph node dissection (CLND). We built a nomogram for prediction of NSN status in melanoma patients with positive SNB. Methods: Data on anthropometric and clinicopathological features of patients with cutaneous melanoma who underwent CLND after a positive SNB were collected from nine Italian centers. Multivariate logistic regression was utilized to identify predictors of NSN status in a training set, while model efficiency was validated in a validation set. Results: Data …

OncologyMaleSkin NeoplasmsSettore MED/19 - Chirurgia PlasticaLogistic regressionSurgery; Oncology; Sentinel Node Biopsy; Melanoma0302 clinical medicineRisk FactorsMedicine030212 general & internal medicineLymph nodeMelanomaSurgery Oncology lymphnodes melanoma metastasis dissection biomarkerslymphnodesMelanomaTorsoSentinel nodeMiddle AgedTumor Burdenmedicine.anatomical_structuredissectionItalyOncologyHead and Neck Neoplasms030220 oncology & carcinogenesisArea Under CurveLymphatic MetastasisSurgery; OncologyFemalemedicine.medical_specialtyNO03 medical and health sciencesSentinel Node BiopsyInternal medicinemetastasisHumansAgedRetrospective StudiesReceiver operating characteristicbusiness.industrySentinel Lymph Node BiopsybiomarkersExtremitiesNomogrammedicine.diseaseConfidence intervalNomogramsROC CurveCutaneous melanomaLymph Node ExcisionSurgeryLymph Nodesbusiness
researchProduct

Flower lose, a cell fitness marker, predicts COVID‐19 prognosis

2021

Abstract Risk stratification of COVID‐19 patients is essential for pandemic management. Changes in the cell fitness marker, hFwe‐Lose, can precede the host immune response to infection, potentially making such a biomarker an earlier triage tool. Here, we evaluate whether hFwe‐Lose gene expression can outperform conventional methods in predicting outcomes (e.g., death and hospitalization) in COVID‐19 patients. We performed a post‐mortem examination of infected lung tissue in deceased COVID‐19 patients to determine hFwe‐Lose’s biological role in acute lung injury. We then performed an observational study (n = 283) to evaluate whether hFwe‐Lose expression (in nasopharyngeal samples) could accu…

OncologyMedicine (General)medicine.medical_specialtyFlowersDiseaseQH426-470Lung injurySeverity of Illness Indexcell fitnessArticleR5-920COVID‐19Internal medicineSeverity of illnessGeneticsmedicineHumansPandemicsRetrospective StudiesReceiver operating characteristicSARS-CoV-2business.industryCOVID-19Retrospective cohort studyArticlesTriageMicrobiology Virology & Host Pathogen InteractionflowerROC CurvebiomarkerMolecular MedicineBiomarker (medicine)Observational studyprognosisbusinessBiomarkersEMBO Molecular Medicine
researchProduct

Prognostic factors for progression-free and overall survival in advanced biliary tract cancer

2015

BACKGROUND: Biliary tract cancer is an uncommon cancer with a poor outcome. We assembled data from the National Cancer Research Institute (UK) ABC-02 study and 10 international studies to determine prognostic outcome characteristics for patients with advanced disease.METHODS: Multivariable analyses of the final dataset from the ABC-02 study were carried out. All variables were simultaneously included in a Cox proportional hazards model, and backward elimination was used to produce the final model (using a significance level of 10%), in which the selected variables were associated independently with outcome. This score was validated externally by receiver operating curve (ROC) analysis using…

Oncologymedicine.medical_specialtyDisease-Free SurvivalCholangiocarcinoma03 medical and health sciencesAdvanced diseaseCisplatin and gemcitabine0302 clinical medicineInternal medicinemedicineJournal ArticleHumansProgression-free survivalProportional Hazards ModelsPerformance statusReceiver operating characteristicManchester Cancer Research Centrebusiness.industryProportional hazards modelResearch Support Non-U.S. Gov'tResearchInstitutes_Networks_Beacons/mcrcHazard ratioArea under the curveCancerHematologymedicine.diseasePrognosisConfidence intervalSurgeryTreatment OutcomeOncologyBile Duct NeoplasmsROC Curve030220 oncology & carcinogenesisABC-02Multivariate AnalysisBiliary tract cancer030211 gastroenterology & hepatologybusinessPerformance statusPrognostic modelMeta-Analysis
researchProduct

Diagnostic and prognostic value of three micrornas in environmental asbestiform fibers-associated malignant mesothelioma

2021

Fluoro-edenite (FE) is an asbestiform fiber identified in Biancavilla (Sicily, Italy). Environmental exposure to FE has been associated with a higher incidence of malignant mesothelioma (MM). The present study aimed to validate the predicted diagnostic significance of hsa-miR-323a-3p, hsa-miR-101-3p, and hsa-miR-20b-5p on a subset of MM patients exposed to FE and matched with healthy controls. For this purpose, MM tissues vs. nonmalignant pleura tissues were analyzed through droplet digital PCR (ddPCR) to evaluate differences in the expression levels of the selected miRNAs and their MM diagnostic potential. In addition, further computational analysis has been performed to establish the corr…

Oncologymedicine.medical_specialtyFluoro-edenitediagnosisMedicine (miscellaneous)AsbestoAsbestiformmedicine.disease_causeAsbestosArticleInternal medicinemicroRNAmedicineDigital polymerase chain reactionMesotheliomaMalignant mesotheliomaReceiver operating characteristicbusiness.industryIncidence (epidemiology)RMicroRNAEnvironmental exposuremedicine.diseaseasbestosPrognosisMedicinebusinessDiagnosi
researchProduct

Tumor Size, an Additional Risk Factor of Local Recurrence in Low-Risk Endometrial Cancer: A Large Multicentric Retrospective Study.

2018

ObjectiveThe identification of patients with endometrial cancer (EC) at higher risk for relapse is critical to individualize and better tailor postoperative treatment. No evidence is available regarding the possible association between tumor size (TS) and the risk of local recurrence. The purpose of this study was to analyze the correlation between TS and risk/type of recurrence in EC patients, stratified according to the new European Society of Medical Oncology-European Society of Gynecological Oncology-European Society for Radiotherapy and Oncology classification.MethodsData of patients with histologically proven EC who received primary surgical treatment between November 1999 and June 20…

Oncologymedicine.medical_specialtyPrognostic factormedicine.medical_treatmentRome03 medical and health sciencesEndometrium0302 clinical medicineEndometrial cancerRetrospective StudieRisk FactorsInternal medicinemedicineLocal recurrenceHumansEndometrial NeoplasmRisk factorAgedRetrospective Studies030219 obstetrics & reproductive medicineReceiver operating characteristicTumor sizebusiness.industryRisk FactorEndometrial cancerDistant relapseLocal relapseObstetrics and GynecologyRetrospective cohort studyTumor sizeMiddle Agedmedicine.diseaseEndometrial NeoplasmsRadiation therapyEndometrial cancer; Local recurrence; Local relapse; Tumor size; Vaginal relapse; Oncology; Obstetrics and GynecologyNeoplasm RecurrenceSettore MED/40 - GINECOLOGIA E OSTETRICIALocalReproductive MedicineOncology030220 oncology & carcinogenesisFemaleNeoplasm Recurrence LocalbusinessVaginal relapseHumanInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society
researchProduct